Opportunity
DIBBS #SPE2DP-26-T-2796
DLA Solicitation for Ceftriaxone Injection, USP – Military Delivery
Posted
April 10, 2026
Respond By
April 15, 2026
Identifier
SPE2DP-26-T-2796
NAICS
325412, 424210
This procurement opportunity from the Defense Logistics Agency (DLA) seeks Ceftriaxone Injection, USP, for delivery to military facilities. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - OEMs (Original Equipment Manufacturers): - HIKMA PHARMACEUTICALS USA INC. (NDC00143-9857-25) - SAGENT PHARMACEUTICALS, INC (NDC25021-0106-10) - WG CRITICAL CARE, LLC (NDC44567-0701-25) - Products Requested: - Ceftriaxone Injection, USP, 1 gram strength, single-use vials, 25 vials per package - National Stock Number (NSN): 6505-01-554-4282 - Total quantity: 5 packages (4 under CLIN 0001, 1 under CLIN 0002) - Each package must have a shelf life of 24 months (minimum 21 months remaining at receipt), be stored at 20 to 25°C, protected from light, and labeled per Medical Marking Standard No. 1A - Notable Requirements: - Strict packaging, labeling, and shelf-life standards - Compliance with domestic sourcing laws and cybersecurity standards - Delivery required within 20 days to specified military bases - Delivery Locations: - Eglin Air Force Base, FL - Fort Bragg, NC
Description
CEFTRIAXONE INJECTI (QTY: 1, NSN: 6505-01-554-4282, Purchase Request: 7016257603) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC
CEFTRIAXONE INJECTI (QTY: 4, NSN: 6505-01-554-4282, Purchase Request: 7016257423) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC